Literature DB >> 24490129

Review: Modulation of striatal neuron activity by cyclic nucleotide signaling and phosphodiesterase inhibition.

Sarah Threlfell1, Anthony R West2.   

Abstract

The cyclic nucleotides cAMP and cGMP are common signaling molecules synthesized in neurons following the activation of adenylyl or guanylyl cyclase. In the striatum, the synthesis and degradation of cAMP and cGMP is highly regulated as these second messengers have potent effects on the activity of striatonigral and striatopallidal neurons. This review will summarize the literature on cyclic nucleotide signaling in the striatum with a particular focus on the impact of cAMP and cGMP on the membrane excitability of striatal medium-sized spiny output neurons (MSNs). The effects of non-selective and selective phosphodiesterase (PDE) inhibitors on membrane activity and synaptic plasticity of MSNs will also be reviewed. Lastly, this review will discuss the implications of the effects PDE modulation on electrophysiological activity of striatal MSNs as it relates to the treatment of neurological disorders such as Huntington's and Parkinson's disease.

Entities:  

Keywords:  cyclic AMP; cyclic GMP; electrophysiology; phosphodiesterase

Year:  2013        PMID: 24490129      PMCID: PMC3904398          DOI: 10.1016/j.baga.2013.08.001

Source DB:  PubMed          Journal:  Basal Ganglia        ISSN: 2210-5336


  115 in total

1.  Modulation by dopamine D1-like receptors of synaptic transmission and NMDA receptors in rat nucleus accumbens is attenuated by the protein kinase C inhibitor Ro 32-0432.

Authors:  K Chergui; M G Lacey
Journal:  Neuropharmacology       Date:  1999-02       Impact factor: 5.250

Review 2.  The neurobiology of slow synaptic transmission.

Authors:  P Greengard
Journal:  Science       Date:  2001-11-02       Impact factor: 47.728

3.  Glutamate modulates sodium-potassium-ATPase through cyclic GMP and cyclic GMP-dependent protein kinase in rat striatum.

Authors:  Carolina Demarchi Munhoz; Elisa Mitiko Kawamoto; Larissa de Sá Lima; Lucilia Brochado Lepsch; Isaias Glezer; Tania Marcourakis; Cristoforo Scavone
Journal:  Cell Biochem Funct       Date:  2005 Mar-Apr       Impact factor: 3.685

4.  Phosphodiesterase 10A (PDE10A) localization in the R6/2 mouse model of Huntington's disease.

Authors:  Alessandro Leuti; Daunia Laurenti; Carmela Giampà; Elena Montagna; Clemente Dato; Serenella Anzilotti; Mariarosa A B Melone; Giorgio Bernardi; Francesca R Fusco
Journal:  Neurobiol Dis       Date:  2012-12-07       Impact factor: 5.996

5.  Nitric oxide-soluble guanylyl cyclase signaling regulates corticostriatal transmission and short-term synaptic plasticity of striatal projection neurons recorded in vivo.

Authors:  Stephen Sammut; Sarah Threlfell; Anthony R West
Journal:  Neuropharmacology       Date:  2009-12-05       Impact factor: 5.250

6.  The distribution of phosphodiesterase 2A in the rat brain.

Authors:  D T Stephenson; T M Coskran; M P Kelly; R J Kleiman; D Morton; S M O'Neill; C J Schmidt; R J Weinberg; F S Menniti
Journal:  Neuroscience       Date:  2012-09-19       Impact factor: 3.590

7.  Upregulation of guanylyl cyclase expression and activity in striatum of MPTP-induced parkinsonism in mice.

Authors:  Malgorzata Chalimoniuk; Józef Langfort; Nadezda Lukacova; Józef Marsala
Journal:  Biochem Biophys Res Commun       Date:  2004-11-05       Impact factor: 3.575

Review 8.  Dopamine and synaptic plasticity in dorsal striatal circuits controlling action selection.

Authors:  D James Surmeier; Joshua Plotkin; Weixing Shen
Journal:  Curr Opin Neurobiol       Date:  2009-11-05       Impact factor: 6.627

9.  Decreased neuronal nitric oxide synthase messenger RNA and somatostatin messenger RNA in the striatum of Huntington's disease.

Authors:  P J Norris; H J Waldvogel; R L Faull; D R Love; P C Emson
Journal:  Neuroscience       Date:  1996-06       Impact factor: 3.590

10.  Dissecting the contribution of individual receptor subunits to the enhancement of N-methyl-d-aspartate currents by dopamine D1 receptor activation in striatum.

Authors:  Emily L Jocoy; Véronique M André; Damian M Cummings; Shilpa P Rao; Nanping Wu; Amy J Ramsey; Marc G Caron; Carlos Cepeda; Michael S Levine
Journal:  Front Syst Neurosci       Date:  2011-05-11
View more
  23 in total

Review 1.  TAK-063, a novel PDE10A inhibitor with balanced activation of direct and indirect pathways, provides a unique opportunity for the treatment of schizophrenia.

Authors:  Kazunori Suzuki; Haruhide Kimura
Journal:  CNS Neurosci Ther       Date:  2018-01-09       Impact factor: 5.243

2.  cAMPr: A single-wavelength fluorescent sensor for cyclic AMP.

Authors:  Christopher R Hackley; Esteban O Mazzoni; Justin Blau
Journal:  Sci Signal       Date:  2018-03-06       Impact factor: 8.192

3.  Facilitation of corticostriatal transmission following pharmacological inhibition of striatal phosphodiesterase 10A: role of nitric oxide-soluble guanylyl cyclase-cGMP signaling pathways.

Authors:  Fernando E Padovan-Neto; Stephen Sammut; Shreaya Chakroborty; Alexander M Dec; Sarah Threlfell; Peter W Campbell; Vishnu Mudrakola; John F Harms; Christopher J Schmidt; Anthony R West
Journal:  J Neurosci       Date:  2015-04-08       Impact factor: 6.167

4.  Detection of phasic dopamine by D1 and D2 striatal medium spiny neurons.

Authors:  Cedric Yapo; Anu G Nair; Lorna Clement; Liliana R Castro; Jeanette Hellgren Kotaleski; Pierre Vincent
Journal:  J Physiol       Date:  2017-09-02       Impact factor: 5.182

Review 5.  Inhibition of phosphodiesterases as a strategy to achieve neuroprotection in Huntington's disease.

Authors:  Antonella Cardinale; Francesca R Fusco
Journal:  CNS Neurosci Ther       Date:  2018-03-03       Impact factor: 5.243

6.  C-type natriuretic peptide functions as an innate neuroprotectant in neonatal hypoxic-ischemic brain injury in mouse via natriuretic peptide receptor 2.

Authors:  Qingyi Ma; Lubo Zhang
Journal:  Exp Neurol       Date:  2018-03-05       Impact factor: 5.330

7.  Phosphodiesterase-10A Inverse Changes in Striatopallidal and Striatoentopeduncular Pathways of a Transgenic Mouse Model of DYT1 Dystonia.

Authors:  Vincenza D'Angelo; Valentina Castelli; Mauro Giorgi; Silvia Cardarelli; Ilaria Saverioni; Francesca Palumbo; Paola Bonsi; Antonio Pisani; Carmela Giampà; Roberto Sorge; Stefano Biagioni; Francesca R Fusco; Giuseppe Sancesario
Journal:  J Neurosci       Date:  2017-01-23       Impact factor: 6.167

Review 8.  Therapy development in Huntington disease: From current strategies to emerging opportunities.

Authors:  Audrey S Dickey; Albert R La Spada
Journal:  Am J Med Genet A       Date:  2017-12-08       Impact factor: 2.802

9.  Frequency-Dependent Corticostriatal Disinhibition Resulting from Chronic Dopamine Depletion: Role of Local Striatal cGMP and GABA-AR Signaling.

Authors:  Vatsala R Jayasinghe; Eden Flores-Barrera; Anthony R West; Kuei Y Tseng
Journal:  Cereb Cortex       Date:  2017-01-01       Impact factor: 5.357

10.  cGMP mediates short- and long-term modulation of excitability in a decision-making neuron in Aplysia.

Authors:  Amanda Goldner; Jesse Farruggella; Marcy L Wainwright; Riccardo Mozzachiodi
Journal:  Neurosci Lett       Date:  2018-06-28       Impact factor: 3.046

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.